• <nav id="422ee"><strong id="422ee"></strong></nav>
  • <menu id="422ee"><strong id="422ee"></strong></menu>
  • <nav id="422ee"><strong id="422ee"></strong></nav>
  • <nav id="422ee"></nav>
    Enterprise Introduction
    • +
        Apeloa Pharmaceutical Co., Ltd. is a state-level key high-tech enterprise and key enterprise in pharmaceutical industry in Zhejiang Province  .
        Our company is engaged in the research and development, production and sales of pharmaceutical products. The main business is in crude drug (API), contract R & D, production service (CDMO) and preparation (FDF) business. The products are mainly concentrated in cardio-cerebrovascular, anti-infection, anti-tumor and other treatment areas. At present, there are more than 70 kinds of raw materials produced on a large scale, 11 of which are sold more than 100 million, such as hydroxylic acid, Anfid, sartan D- ethyl ester and so on, which account for the absolute share of the global market.
        Headquartered in Hengdian Town, Dongyang City, Zhejiang Province, the company has 7 raw materials production plants and 4 preparation production plants, located in Hengdian and Quzhou in Zhejiang Province, , Weifang in Shandong Province, Chizhou, in Anhui Province, Datong in Shanxi Province. Besides, we have established R & D institutions in Shanghai,Chengdu and Hangzhou in China. We also have set up overseas companies or branches in the United States and Hong Kong .
        In order to improve market competition, our company build core competitiveness continuesly in quality, EHS and technology . Five of the API plants were certified by GMP, four by FDA, three by PMDA, three by CE in EU, one by WHO, one by KFDA, one by Germany GMP, and all of preparation factory were certified by GMP. In addition to the safety and occupational health management system certification, API plants continue to be audited by EHS audits from international pharmaceutical companies or third parties.
        Apeloa is the first national enterprise technology center, with two academicians workstations, two postdoctoral research workstations, a chiral medicine and intermediate technology national engineering research center. Each business department has established a R&D team combining with its own business development. The company R & D team includes 4 provincial "1000 person plan" experts.
        The company adheres to the core value of "mutual creation,mutual ownership, mutual sharing and mutual benefit", focus on creating corporate culture of"learn happily, exercise happily, work happily" , and implement the development strategy of "making fine raw materials, making CDMO stronger and making preparation with good quality". We will promote innovation with culture and drive the future with innovation. We are willing to work together with all sectors of society to make greater and greater contributions to the realization of "healthy dream".
    Management Team
    Organizational Structure
    img img img img
    Development History
    • 1989

      In 1989, Hengdian Industrial Corporation invested in the establishment of Dongyang Pharmaceutical Chemical Plant, Dongyang Organic synthetic Chemical Plant, Yongan Chemical Plant, and began to produce pharmaceutical intermediates.

    • 2001

      In 2001,Hengdian Group replace a part of the pharmaceutical industry and realized “Reverse Merger”

    • 2012

      In 2012, the company listed the whole pharmaceutical assets on the market through the implementation of major asset restructuring

    • 2017

      In 2017,Our Company carried out major adjustment of organizational management structure and development strategy, implementing unified management mode of "functional division".

    Corporate Culture
    • Core Idea
      Create TogetherShareCo RichShare
    • Core Value
      CharityThe Doctrine of the MeanTeamImplement
    • Corporate Culture
      Happy LearningHappy MovementHappy Work
    CopyRight ? 2017 APELOA ZheICP13019407-1ZheICP13019407-1 Powered by:HANSUN
    黄色电影免费片网站大全 - 视频 - 在线观看 - 影视资讯 - 品爱网